San Rafael, CA, United States of America

Yanhong Zhang

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 11.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: The Innovative Contributions of Yanhong Zhang in Biochemical Research

Introduction

Yanhong Zhang, an accomplished inventor based in San Rafael, California, has made significant strides in the field of biochemical research. With a total of two patents, she has showcased her expertise and dedication to advancing scientific knowledge and therapeutic options.

Latest Patents

Zhang's latest patents focus on the compositions of prokaryotic phenylalanine ammonia-lyase (PAL) variants. These variants are produced by prokaryotes and exhibit enhanced phenylalanine-converting activity along with reduced immunogenicity compared to the wild-type PAL. The patents detail not only the compositions of these PAL variants but also include biologically active fragments, mutants, and methods for their production, purification, formulation, and use. These advancements hold promise for industrial and therapeutic applications, particularly in treating conditions such as hyperphenylalaninemia, phenylketonuria, and other disorders, including cancer.

Career Highlights

Zhang currently works with BioMarin Pharmaceutical Inc., a leading biotechnology company focused on developing innovative biopharmaceuticals. Her role at BioMarin allows her to contribute to cutting-edge research that can impact patients' lives positively.

Collaborations

Throughout her career, Zhang has collaborated with notable professionals in the field, including Augustus O. Okhamafe and Sean M. Bell. These collaborations emphasize the collective effort needed in innovation and the importance of teamwork in achieving scientific breakthroughs.

Conclusion

Yanhong Zhang's innovative patents in the realm of prokaryotic phenylalanine ammonia-lyase variants are a testament to her commitment to advancing biotechnology. As she continues her work at BioMarin Pharmaceutical Inc., the implications of her contributions may lead to significant advancements in treating genetic disorders and other serious health conditions. Her inventiveness and collaboration with esteemed colleagues highlight the impactful journey of a dedicated inventor.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…